SPONSOR
Gilead Sciences
Total Trials
3
Recruiting
3
Phases
Phase 1, Phase 2
Gilead Sciences is a clinical research sponsor with 3 registered studies on ClinicalTrials.gov, of which 3 are actively recruiting participants. Research covers conditions including Advanced Solid Tumor, Weight Management, Metastatic Urothelial Cancer.
The trial portfolio spans Phase 1, Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Gilead Sciences
How many clinical trials has Gilead Sciences sponsored?
ClinicalMetric currently tracks 3 clinical trials sponsored by Gilead Sciences, of which 3 are actively recruiting participants. These trials cover conditions including Advanced Solid Tumor, Weight Management, Metastatic Urothelial Cancer. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Gilead Sciences research focus on?
Gilead Sciences clinical trials span Advanced Solid Tumor, Weight Management, Metastatic Urothelial Cancer. The research pipeline includes Phase 1, Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Gilead Sciences clinical trial?
To participate in a Gilead Sciences trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Gilead Sciences trials with current recruitment status updated daily.
Clinical Trials by Gilead Sciences
NCT07128303 Phase 1
Recruiting
Study of GS-5319 in Adults With Solid Tumors
Advanced Solid Tumor
NCT06562907 Phase 1
Recruiting
Study of GS-4571 in Healthy Participants, Nondiabetic Obese Participants, and Nonobese Participants With Type 2 Diabetes Mellitus (T2DM)
Weight Management
NCT03547973 Phase 2
Recruiting
Study of Sacituzumab Govitecan in Participants With Urothelial Cancer That Cannot Be Removed or Has Spread
Metastatic Urothelial Cancer
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: July 2026 · Data Methodology